Bile acid-dependent T cell regulation in the intestine

肠道内胆汁酸依赖性 T 细胞调节

基本信息

  • 批准号:
    10591659
  • 负责人:
  • 金额:
    $ 31.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-06 至 2022-09-01
  • 项目状态:
    已结题

项目摘要

Project Summary Immune-mediated inflammation of the distal small intestine, or ileitis, is a common and debilitating feature of the inflammatory bowel disease, Crohn’s disease. However, the mechanisms governing local immune function and inflammation in the ileum remain poorly defined. This proposal interrogates a novel pathway by which circulating CD4+ T effector (Teff) cells—including IFN-producing Th1 and IL-17A-secreting Th17 cells— compensate for cytotoxic concentrations of bile acids (BAs) in the ileum to safeguard immune homeostasis. Long considered simple emulsifying agents that circulate between the liver and ileum and that facilitate absorption and elimination of dietary lipids, BAs have now emerged as pleiotropic signaling metabolites that regulate host metabolism and inflammation via dynamic interactions with both germline-encoded receptors and the intestinal microbiota. We have shown that Teff cells upregulate expression of the xenobiotic transporter, MDR1, in the ileum to limit oxidative stress, prevent pathogenic cytokine secretion and suppress ileitis in the presence of locally-reabsorbed BAs. We have also identified the constitutive androstane receptor (CAR)–a BA- sensing nuclear receptor with no known function in immune cells—as a driver of MDR1 (Abcb1a) gene expression in mucosal Teff cells. Loss or knockdown of either MDR1 or CAR in Teff cells precipitates severe ileitis upon transfer into immunodeficient Rag1-/- mice. Mechanistically, our data suggest that CAR responds to mucosa-associated BAs in the ileum by activating the expression of numerous drug-processing enzymes and transporters in mucosal Teff cells, including MDR1, to detoxify BAs and enforce local immune homeostasis. This mechanism is directly relevant to the understanding and treatment of Crohn’s disease, as: (i) MDR1 expression in human Teff cells is increased markedly in the intestinal mucosa; (ii) MDR1 loss-of-function is evident in a subset of Crohn’s disease patients; and (iii) cholestyramine, an FDA-approved bile acid sequestrant that blocks BA reabsorption into the ileal mucosa, attenuates ileitis in both T cell transfer and spontaneous mouse models of Crohn’s disease. In addition, this mechanism establishes an unexpected new regulatory function of BAs. Our proposed studies use genetic and pharmacologic approaches, as well as clinically-relevant mouse models of Crohn’s disease, to define the mechanisms by which CAR and its transcriptional targets interact with BAs to enforce immune homeostasis in the ileum. Together, these studies will bring to light an important new pathway underlying local immune homeostasis in the ileum, whilst having important implications for improving our understanding and treatment of human Crohn’s disease.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark Scott Sundrud其他文献

Mark Scott Sundrud的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark Scott Sundrud', 18)}}的其他基金

Bile acid-dependent T cell regulation in the intestine
肠道内胆汁酸依赖性 T 细胞调节
  • 批准号:
    10767546
  • 财政年份:
    2023
  • 资助金额:
    $ 31.44万
  • 项目类别:
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
离散肠道微环境中 T 细胞功能的核受体控制
  • 批准号:
    10757138
  • 财政年份:
    2021
  • 资助金额:
    $ 31.44万
  • 项目类别:
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
离散肠道微环境中 T 细胞功能的核受体控制
  • 批准号:
    10493280
  • 财政年份:
    2021
  • 资助金额:
    $ 31.44万
  • 项目类别:
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
离散肠道微环境中 T 细胞功能的核受体控制
  • 批准号:
    10391961
  • 财政年份:
    2021
  • 资助金额:
    $ 31.44万
  • 项目类别:
Transcript-selective translational control of Th17 cell development and function
Th17 细胞发育和功能的转录选择性翻译控制
  • 批准号:
    10373280
  • 财政年份:
    2021
  • 资助金额:
    $ 31.44万
  • 项目类别:
Transcript-selective translational control of Th17 cell development and function
Th17 细胞发育和功能的转录选择性翻译控制
  • 批准号:
    10591695
  • 财政年份:
    2021
  • 资助金额:
    $ 31.44万
  • 项目类别:
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
离散肠道微环境中 T 细胞功能的核受体控制
  • 批准号:
    10591677
  • 财政年份:
    2021
  • 资助金额:
    $ 31.44万
  • 项目类别:
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
离散肠道微环境中 T 细胞功能的核受体控制
  • 批准号:
    10685603
  • 财政年份:
    2021
  • 资助金额:
    $ 31.44万
  • 项目类别:
Transcript-selective translational control of Th17 cell development and function
Th17 细胞发育和功能的转录选择性翻译控制
  • 批准号:
    10753258
  • 财政年份:
    2021
  • 资助金额:
    $ 31.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了